Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
beta-Cell death during progression to diabetes.
Mathis D, Vence L, Benoist C. Mathis D, et al. Nature. 2001 Dec 13;414(6865):792-8. doi: 10.1038/414792a. Nature. 2001. PMID: 11742411 Review.
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis.
Lande R, Botti E, Jandus C, Dojcinovic D, Fanelli G, Conrad C, Chamilos G, Feldmeyer L, Marinari B, Chon S, Vence L, Riccieri V, Guillaume P, Navarini AA, Romero P, Costanzo A, Piccolella E, Gilliet M, Frasca L. Lande R, et al. Nat Commun. 2014 Dec 3;5:5621. doi: 10.1038/ncomms6621. Nat Commun. 2014. PMID: 25470744
Corrigendum: the antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis.
Lande R, Botti E, Jandus C, Dojcinovic D, Fanelli G, Conrad C, Chamilos G, Feldmeyer L, Marinari B, Chon S, Vence L, Riccieri V, Guillaume P, Navarini AA, Romero P, Costanzo A, Piccolella E, Gilliet M, Frasca L. Lande R, et al. Nat Commun. 2015 Mar 11;6:6595. doi: 10.1038/ncomms7595. Nat Commun. 2015. PMID: 25759123 No abstract available.
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.
Gao J, Ward JF, Pettaway CA, Shi LZ, Subudhi SK, Vence LM, Zhao H, Chen J, Chen H, Efstathiou E, Troncoso P, Allison JP, Logothetis CJ, Wistuba II, Sepulveda MA, Sun J, Wargo J, Blando J, Sharma P. Gao J, et al. Nat Med. 2017 May;23(5):551-555. doi: 10.1038/nm.4308. Epub 2017 Mar 27. Nat Med. 2017. PMID: 28346412 Free PMC article.
MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
Li Y, Liu S, Hernandez J, Vence L, Hwu P, Radvanyi L. Li Y, et al. J Immunol. 2010 Jan 1;184(1):452-65. doi: 10.4049/jimmunol.0901101. Epub 2009 Nov 30. J Immunol. 2010. PMID: 19949105
Development and application of 'phosphoflow' as a tool for immunomonitoring.
Wu S, Jin L, Vence L, Radvanyi LG. Wu S, et al. Expert Rev Vaccines. 2010 Jun;9(6):631-43. doi: 10.1586/erv.10.59. Expert Rev Vaccines. 2010. PMID: 20518718 Free PMC article. Review.
Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.
Kuerer HM, Buzdar AU, Mittendorf EA, Esteva FJ, Lucci A, Vence LM, Radvanyi L, Meric-Bernstam F, Hunt KK, Symmans WF. Kuerer HM, et al. Cancer. 2011 Jan 1;117(1):39-47. doi: 10.1002/cncr.25399. Epub 2010 Aug 24. Cancer. 2011. PMID: 20740500 Free PMC article. Clinical Trial.
Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy.
Cohen L, Parker PA, Vence L, Savary C, Kentor D, Pettaway C, Babaian R, Pisters L, Miles B, Wei Q, Wiltz L, Patel T, Radvanyi L. Cohen L, et al. Psychosom Med. 2011 Apr;73(3):218-25. doi: 10.1097/PSY.0b013e31820a1c26. Epub 2011 Jan 21. Psychosom Med. 2011. PMID: 21257977 Clinical Trial.
BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competency.
Hong DS, Vence L, Falchook G, Radvanyi LG, Liu C, Goodman V, Legos JJ, Blackman S, Scarmadio A, Kurzrock R, Lizee G, Hwu P. Hong DS, et al. Clin Cancer Res. 2012 Apr 15;18(8):2326-35. doi: 10.1158/1078-0432.CCR-11-2515. Epub 2012 Feb 21. Clin Cancer Res. 2012. PMID: 22355009 Clinical Trial.
56 results
Jump to page
Feedback